Wednesday Jul 29, 2026

Leadership Transition: Michael Polk Assumes Interim CEO Role at Implus Corporation

Implus Corporation, the leading provider of athletic and outdoor accessories, has announced the appointment of Michael B. Polk as Interim Chief Executive Officer. This leadership transition comes as Seth Richards and Todd Vore, the current CEO and President, respectively, are stepping down to pursue other opportunities.  The Implus Corporation Board of Directors expressed their gratitude […]

Blarcamesine Deemed Safe and Effective in Parkinson Disease Dementia Study: Anavex Life Sciences Reports Promising Results

Anavex Life Sciences, a leading biopharmaceutical company, has recently announced positive findings from their phase 2 study of blarcamesine, also known as ANAVEX2-73, in patients with Parkinson disease dementia (PDD). The study, ANAVEX2-73-PDD-EP-001, included a 48-week, open-label extension phase, and the results have shown that blarcamesine met its primary and secondary objectives in improving PDD […]

Back to Top